At ISPOR 2025 in Montreal, PurpleLab presented a research poster titled “Intersectional Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA) for Social Determinants of Health and Pregnancy Outcomes.” The study, conducted by Anna Wang, PhD, Francis Concannon, BS, Daria Eremina, PhD, and Douglas Londono, PhD, applied MAIHDA to analyze how overlapping social factors influence…

Pharma advertising measurement has been stuck in the past. But it doesn’t have to be.  For years, pharma marketers have been stuck chasing the wrong numbers. Impressions. Clicks. Bounce rates. The list goes on. These vanity metrics might look good on a dashboard, but they don’t tell you if your campaign actually moved the needle….

Real-world data in life sciences is doing what once seemed impossible: challenging the dominance of traditional clinical trials. For decades, clinical trials have been the gold standard in life sciences research. And it makes sense: they’re rigorously controlled and designed to ensure that the true effects of drugs are being measured. But the real world…

Real-World Data: The Cornerstone of Life Science Consulting Life sciences are at an inflection point. As pressure mounts to develop therapies faster, prove real-world value to payers, and personalize interventions, traditional data sources are hitting their limits. Real-world data (RWD), particularly claims data, has emerged as a critical lever across the product lifecycle. For consultancies,…

Discover how a clinical trial overcame patient enrollment challenges by addressing PI expertise misalignment and leveraging data-driven referral tools.

Clinical trials tell you a lot – but they don’t tell you everything you need to know to truly compete in today’s saturated pharma market. Sure, they’re the gold standard for proving safety and efficacy. But once a drug hits the real world, all bets are off. Patients don’t follow protocols. Even providers don’t always…

The Old Operating System Is Crashing Let’s be honest: pharma’s old operating system is starting to show its age. The traditional model – built around blockbuster drugs, top-down messaging and rigid pipelines – is crashing under the weight of modern complexity. Shareholder returns are sluggish. CEOs are second-guessing legacy bets. The pressure to demonstrate real…

The healthcare industry is undergoing a seismic shift as price transparency regulations gain momentum, driven by executive orders and federal rulemaking. These regulations aim to empower patients with actionable pricing information and foster accountability among healthcare providers and payers. However, enforcement challenges and data complexities have revealed gaps that need innovative solutions. In this article,…

Digital health solutions are increasingly common in healthcare, with over
300,000 health apps available and more than half of U.S. adults using
digital health tools.